FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089344570> ?p ?o ?g. }

• W2089344570 endingPage "1177" @default.
• W2089344570 startingPage "1171" @default.
• W2089344570 abstract "Substance P (SP) and calcitonin gene-related peptide (CGRP) are well established mediators of inflammation. Therefore, inhibition of the biosynthesis of these neuropeptides is an attractive potential strategy for pharmacological intervention against a number of inflammatory diseases. The final step in the biosynthesis of SP and CGRP is the conversion of their glycine-extended precursors to the active amidated peptide, and this process is catalyzed by sequential action of the enzymes peptidylglycine alpha-monooxygenase (PAM) and peptidylamidoglycolate lyase. We have demonstrated previously that 4-phenyl-3-butenoic acid (PBA) is a PAM inhibitor, and we have also shown that in vivo inhibition of serum PAM by PBA correlates with this compound's ability to inhibit carrageenan-induced edema in the rat. Here we demonstrate the ability of PBA to inhibit all three phases of adjuvant-induced polyarthritis (AIP) in rats; this represents the first time that an amidation inhibitor has been shown to be active in a model of chronic inflammation. We recently introduced 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid (AOPHA) as one of a new series of mechanism-based amidation inhibitors. We now report for the first time that AOPHA and its methyl ester (AOPHA-Me) are active inhibitors of serum PAM in vivo, and we show that AOPHA-Me correspondingly inhibits carrageenan-induced edema in rats in a dose-dependent manner. Neither PBA nor AOPHA-Me exhibits significant cyclooxygenase (COX) inhibition in vitro; thus, the anti-inflammatory activities of PBA and AOPHA-Me are apparently not a consequence of COX inhibition. We discuss possible pharmacological mechanisms that may account for the activities of these new anti-inflammatory compounds." @default.
• W2089344570 created "2016-06-24" @default.
• W2089344570 creator A5001016899 @default.
• W2089344570 creator A5001048559 @default.
• W2089344570 creator A5010965657 @default.
• W2089344570 creator A5021055730 @default.
• W2089344570 creator A5031938363 @default.
• W2089344570 creator A5047269123 @default.
• W2089344570 creator A5063265755 @default.
• W2089344570 creator A5078313219 @default.
• W2089344570 date "2006-11-30" @default.
• W2089344570 modified "2023-10-13" @default.
• W2089344570 title "Anti-Inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation" @default.
• W2089344570 cites W126816316 @default.
• W2089344570 cites W1506532063 @default.
• W2089344570 cites W1524414759 @default.
• W2089344570 cites W1667375729 @default.
• W2089344570 cites W1965765982 @default.
• W2089344570 cites W1968544303 @default.
• W2089344570 cites W1980805742 @default.
• W2089344570 cites W1981104446 @default.
• W2089344570 cites W1984062654 @default.
• W2089344570 cites W1985580976 @default.
• W2089344570 cites W1991275375 @default.
• W2089344570 cites W1992165642 @default.
• W2089344570 cites W1993457381 @default.
• W2089344570 cites W2007995076 @default.
• W2089344570 cites W2013247237 @default.
• W2089344570 cites W2014388474 @default.
• W2089344570 cites W2023664228 @default.
• W2089344570 cites W2024335394 @default.
• W2089344570 cites W2035168968 @default.
• W2089344570 cites W2052945397 @default.
• W2089344570 cites W2055728171 @default.
• W2089344570 cites W2061035160 @default.
• W2089344570 cites W2065001772 @default.
• W2089344570 cites W2065850187 @default.
• W2089344570 cites W2066074947 @default.
• W2089344570 cites W2089335473 @default.
• W2089344570 cites W2105678915 @default.
• W2089344570 cites W2118488788 @default.
• W2089344570 cites W2137852743 @default.
• W2089344570 cites W2174787058 @default.
• W2089344570 cites W2323727781 @default.
• W2089344570 cites W4244311005 @default.
• W2089344570 doi "https://doi.org/10.1124/jpet.106.110940" @default.
• W2089344570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17138865" @default.
• W2089344570 hasPublicationYear "2006" @default.
• W2089344570 type Work @default.
• W2089344570 sameAs 2089344570 @default.
• W2089344570 citedByCount "13" @default.
• W2089344570 countsByYear W20893445702013 @default.
• W2089344570 countsByYear W20893445702014 @default.
• W2089344570 countsByYear W20893445702015 @default.
• W2089344570 countsByYear W20893445702022 @default.
• W2089344570 crossrefType "journal-article" @default.
• W2089344570 hasAuthorship W2089344570A5001016899 @default.
• W2089344570 hasAuthorship W2089344570A5001048559 @default.
• W2089344570 hasAuthorship W2089344570A5010965657 @default.
• W2089344570 hasAuthorship W2089344570A5021055730 @default.
• W2089344570 hasAuthorship W2089344570A5031938363 @default.
• W2089344570 hasAuthorship W2089344570A5047269123 @default.
• W2089344570 hasAuthorship W2089344570A5063265755 @default.
• W2089344570 hasAuthorship W2089344570A5078313219 @default.
• W2089344570 hasConcept C118303440 @default.
• W2089344570 hasConcept C126322002 @default.
• W2089344570 hasConcept C13002179 @default.
• W2089344570 hasConcept C150903083 @default.
• W2089344570 hasConcept C163170386 @default.
• W2089344570 hasConcept C170493617 @default.
• W2089344570 hasConcept C181199279 @default.
• W2089344570 hasConcept C185592680 @default.
• W2089344570 hasConcept C202751555 @default.
• W2089344570 hasConcept C207001950 @default.
• W2089344570 hasConcept C2776914184 @default.
• W2089344570 hasConcept C2777756961 @default.
• W2089344570 hasConcept C2779627488 @default.
• W2089344570 hasConcept C2779689624 @default.
• W2089344570 hasConcept C2781227287 @default.
• W2089344570 hasConcept C515207424 @default.
• W2089344570 hasConcept C526171541 @default.
• W2089344570 hasConcept C55493867 @default.
• W2089344570 hasConcept C71240020 @default.
• W2089344570 hasConcept C71924100 @default.
• W2089344570 hasConcept C86803240 @default.
• W2089344570 hasConcept C98274493 @default.
• W2089344570 hasConceptScore W2089344570C118303440 @default.
• W2089344570 hasConceptScore W2089344570C126322002 @default.
• W2089344570 hasConceptScore W2089344570C13002179 @default.
• W2089344570 hasConceptScore W2089344570C150903083 @default.
• W2089344570 hasConceptScore W2089344570C163170386 @default.
• W2089344570 hasConceptScore W2089344570C170493617 @default.
• W2089344570 hasConceptScore W2089344570C181199279 @default.
• W2089344570 hasConceptScore W2089344570C185592680 @default.
• W2089344570 hasConceptScore W2089344570C202751555 @default.
• W2089344570 hasConceptScore W2089344570C207001950 @default.
• W2089344570 hasConceptScore W2089344570C2776914184 @default.
• W2089344570 hasConceptScore W2089344570C2777756961 @default.

• next